Shuttle Pharmaceuticals Holdings, Inc. announced that it has entered into a securities purchase agreement with new investor, SRO, LLC to issue units for the gross proceeds of $2,250,000 on February 7, 2024. Each unit consists of one share of SHPH common stock and a warrant to purchase one share of SHPH common stock exercisable at a purchase price of $2.35 per share. The Units will be sold at a per Unit price equal to 90% of the VWAP of SHPH common stock for the five trading days immediately preceding closing.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5248 USD | -1.17% | +18.25% | +15.34% |
1st Jan change | Capi. | |
---|---|---|
+15.34% | 8.93M | |
+42.37% | 739B | |
+32.34% | 598B | |
-5.38% | 353B | |
+17.72% | 318B | |
+3.73% | 285B | |
+16.55% | 240B | |
+9.21% | 210B | |
-5.40% | 206B | |
+7.13% | 164B |
- Stock Market
- Equities
- SHPH Stock
- News Shuttle Pharmaceuticals Holdings, Inc.
- Shuttle Pharmaceuticals Holdings, Inc. announced that it expects to receive $2.25 million in funding